Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.

Authors : Strzelczyk, Adam^1,2,3 (AUTHOR) ; Knake, Susanne^2,3 (AUTHOR); Kälviäinen, Reetta^4,5 (AUTHOR)

Source: Acta Neurologica Scandinavica. Apr2019, Vol. 139 Issue 4, p369-376. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Super-Refractory Status Epilepticus Treated with High Dose Perampanel: Case Series and Review of the Literature.

Authors : Newey, Christopher R.^1,2; Mullaguri, Naresh¹; Hantus, Stephen^1,2

Source: Case Reports in Critical Care. 9/2/2019, p1-7. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

ALSUntangled 48: Perampanel (Fycompa).

Authors : Bedlack, Rick (AUTHOR)

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Aug2019, Vol. 20 Issue 5/6, p453-456. 4p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy.

Authors : Yuni Yun¹; Dongsub Kim²; Yun-Jeong Lee¹

Source: Korean Journal of Pediatrics. Jul2019, Vol. 62 Issue 7, p269-273. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis.

Authors : Maschio, Marta¹ ; Pauletto, Giada²; Zarabla, Alessia¹

Source: International Journal of Neuroscience. Jun2019, Vol. 129 Issue 6, p593-597. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid.

Authors : Liguori, Claudio¹ (AUTHOR) ; Turner, Katherine² (AUTHOR); Izzi, Francesca¹ (AUTHOR)

Source: CNS Neuroscience & Therapeutics. May2019, Vol. 25 Issue 5, p632-637. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.

Authors : Lange, Falko^1,2 ; Weßlau, Konrad¹; Porath, Katrin¹

Source: PLoS ONE. 2/4/2019, Vol. 14 Issue 2, p1-17. 17p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus.

Authors : Rahbani, Abdallah^1,2; Adwane, Grace¹; Jomaa, Najo¹

Source: Case Reports in Neurological Medicine. 4/9/2019, p1-3. 3p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents.

Authors : Lai, Ming-Chi¹ (AUTHOR) ; Tzeng, Ray-Chang² (AUTHOR) ; Huang, Chin-Wei³ (AUTHOR)

Source: Biomolecules (2218-273X). Oct2019, Vol. 9 Issue 10, p638. 1p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Perampanel is also a useful adjunctive treatment option in refractory epilepsy in children.

Authors : Jon Soo Kim¹ ; Won Seop Kim¹

Source: Korean Journal of Pediatrics. Jul2019, Vol. 62 Issue 7, p259-260. 2p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.

Super-Refractory Status Epilepticus Treated with High Dose Perampanel: Case Series and Review of the Literature.

ALSUntangled 48: Perampanel (Fycompa).

Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy.

Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis.

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid.

AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.

Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus.

The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents.

Perampanel is also a useful adjunctive treatment option in refractory epilepsy in children.

اتصل بنا

اتبع